+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Amniocentesis Needle Market - Growth, Trends, and Forecasts (2020 - 2025)

  • PDF Icon


  • 110 Pages
  • June 2020
  • Region: Global
  • Mordor Intelligence
  • ID: 4617255
The market for amniocentesis is expected to grow steadily over the forecast period. Certain factors that are responsible for the growth of this market are the growing median age of first-time motherhood, the increasing burden of the congenital diseases, and the high reliability of people on amniocentesis.

Amniocentesis is almost 99.4% accurate and this test determines if the baby in the womb has any genetic or chromosomal abnormalities. The test can identify many genetic disorders, such as Down syndrome, Edward’s syndrome, Tay-Sachs disease, Huntington’s disease, sickle cell disease, and cystic fibrosis. It can provide the information needed to diagnosis these complications in the fetus. Due to the high reliability of the test, its adoption is good across several healthcare facilities, therefore the market is expected to expand over the forecast period.

Key Market Trends

Amniocentesis Procedure is Expected to Show Steady Growth Over the Forecast Period

Rising concern about genetic disorders is the major factor responsible for the growing number of procedures. Various studies have been conducted by organizations such as the National Institute of Health (NIH) to understand the risks associated with amniocentesis procedure and the challenges during the same. Studies have revealed that the occurrence of early abortion after amniocentesis is a major risk and its prevalence is around 10%. However, the technical advancements in the needles, and the focus of medical professionals on the safety of the patient, it is expected that the instances of early abortions will be reduced in the near future. Furthermore, the increasing birth rate globally is enhancing market growth. India is the leading country in terms of having the highest birthrate.

Therefore, due to the increasing birth rate, rising number of amniocentesis procedures, growing adoption of the same, and increasing focus on patient safety, the amniocentesis procedure segment is expected to show steady growth over the forecast period.

North America to Maintain Lead in the Amniocentesis Market

The global amniocentesis needle market is dominated by North America and Europe respectively. North America will continue to dominate the global market over the forecast period. Factors, such as the rising government initiatives and an increasing number of amniocentesis procedures, are driving the growth of the market in this region.

The developed healthcare system in the United States is augmenting the demand for advanced products which is accelerating the growth of amniocentesis needles with advanced technology. Added to that, a concern of the general population in the North America region about the genetic disorders in a newborn is propelling the demand for amniocentesis procedure.

Competitive Landscape

The market for amniocentesis needles is moderately competitive and is comprised mostly of local companies. Countries like China and India are having a large number of local suppliers for the amniocentesis needles which is posing an intense competition among these local companies. The market is also witnessing the presence of global companies but the competition among the big players is comparatively lower than that of the local players.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Reliability of Amniocentesis
4.2.2 Growing Median Age of First-Time Motherhood
4.2.3 Increasing Burden of Congenital Disorders
4.3 Market Restraints
4.3.1 Availability of Alternate Methods
4.3.2 Lack of Skilled Professionals
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Type
5.1.1 100 to 150 mm Needles
5.1.2 Larger Than 150 mm Needles
5.1.3 Smaller Than 100 mm Needles
5.2 By Procedure
5.2.1 Amniocentesis Procedures
5.2.2 Amnioreduction Procedures
5.2.3 Fetal Blood Transfusion Procedures
5.2.4 Amnioinfusion Procedures
5.2.5 Cordocentesis Procedures
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 The Ccoper Companis Inc.
6.1.2 Becton, Dickinson and Company
6.1.3 Cook Medical Incorporated
6.1.4 RI.MOS. Srl
6.1.5 Smiths Medical
6.1.6 Laboratoire Ccd
6.1.7 Integra Lifesciences
6.1.8 Medtronic Plc
6.1.9 Medline Industries Inc.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • The Ccoper Companis Inc.
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • RI.MOS. Srl
  • Smiths Medical
  • Laboratoire Ccd
  • Integra Lifesciences
  • Medtronic Plc
  • Medline Industries Inc.